chrisvoncsefalvay/vaers-outcomes huggingface dataset:
back pain; chest pain; sweating bricks; extremely weak; sore arm that I cannot move; feel the heat in my throat; slight coughing; hurts when someone touches me anywhere on my body/sore arm that I cannot move; bad headache; chills all over; tired; nauseous so I have not eaten; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back pain), CHEST PAIN (chest pain), HYPERHIDROSIS (sweating bricks), ASTHENIA (extremely weak) and VACCINATION SITE JOINT MOVEMENT IMPAIRMENT (sore arm that I cannot move) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BACK PAIN (back pain), CHEST PAIN (chest pain), HYPERHIDROSIS (sweating bricks), ASTHENIA (extremely weak), VACCINATION SITE JOINT MOVEMENT IMPAIRMENT (sore arm that I cannot move), OROPHARYNGEAL DISCOMFORT (feel the heat in my throat), COUGH (slight coughing), MYALGIA (hurts when someone touches me anywhere on my body/sore arm that I cannot move), HEADACHE (bad headache), CHILLS (chills all over), FATIGUE (tired) and NAUSEA (nauseous so I have not eaten). At the time of the report, BACK PAIN (back pain), CHEST PAIN (chest pain), HYPERHIDROSIS (sweating bricks), ASTHENIA (extremely weak), VACCINATION SITE JOINT MOVEMENT IMPAIRMENT (sore arm that I cannot move), OROPHARYNGEAL DISCOMFORT (feel the heat in my throat), COUGH (slight coughing), MYALGIA (hurts when someone touches me anywhere on my body/sore arm that I cannot move), HEADACHE (bad headache), CHILLS (chills all over), FATIGUE (tired) and NAUSEA (nauseous so I have not eaten) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication was not given.  No concomitant medications was reported.
This spontaneous report was received from a physician, via company representatives and from a support services director, concerning to a patient of unknown age and gender. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On 14-AUG-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 10 single Ds 0.5 ml VIs 10 SDV (lot number and expiration date: K007262 and 25-NOV-2015 respectively; route of administration was not provided). The vaccine had multiple excursion varying from 28.9 degrees Fahrenheit (-1.72 degrees Celsius) (lowest recorded temperature) for 48 hours to 64.8 degrees Fahrenheit (18.22 degrees Celsius) (highest recorded temperature) for 24 hours. The vaccine status was reported and "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient received 2nd dose of Pfizer Ped. After the injection, patient sat down and after about a minute fainted. The father of the patient picked him up and the patient had a spasm upon waking up. The patient was seated again and 9-1-1 was called. The patient said he felt a little dizzy and had a headache. The EMT's came and evaluated the patient and the blood pressure was low. After sitting for about 30 minutes patient felt better and the parents took the patient home. They will follow up with the patient's pediatrician.
burning in both eyes; headache; dry eye; in both eye sockets; Pain was worst/pain was getting worse; felt lot like reaction I had to thimerosal; This spontaneous case was reported by a consumer and describes the occurrence of EYE IRRITATION (burning in both eyes), HEADACHE (headache), DRY EYE (dry eye), EYE PAIN (in both eye sockets) and PAIN (Pain was worst/pain was getting worse) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046120A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Previously administered products included for an unreported indication: THIMEROSAL (Patient reported that she had the same adverse events when had to thimerosal).   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.  On 14-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.   On 17-Feb-2021, the patient experienced PAIN (Pain was worst/pain was getting worse) and UNEVALUABLE EVENT (felt lot like reaction I had to thimerosal).   On an unknown date, the patient experienced EYE IRRITATION (burning in both eyes), HEADACHE (headache), DRY EYE (dry eye) and EYE PAIN (in both eye sockets).   At the time of the report, EYE IRRITATION (burning in both eyes), HEADACHE (headache), DRY EYE (dry eye), EYE PAIN (in both eye sockets) and PAIN (Pain was worst/pain was getting worse) outcome was unknown and UNEVALUABLE EVENT (felt lot like reaction I had to thimerosal) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Two swollen lymph nodes above left clavicle.; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 26Feb2021 at 08:15 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included fluconazole (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously took vancomycin (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. On 05Mar2021, the patient experienced two swollen lymph nodes above the left clavicle. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event two swollen lymph nodes above left clavicle was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
This case was reported by a consumer and described the occurrence of loss of appetite in a 55-year-old male subject who was vaccinated with TWINRIX adult (GlaxoSmithKline) and Influenza vaccine (manufacturer unspecified) to cure Hepatitis C as a part of program 8 years ago. A physician or other health care professional has not verified this report. Concurrent medical conditions included Hepatitis C. On unspecified dates, the subject received 4 doses of TWINRIX adult one week apart (unknown routes and injection sites, batch numbers not provided). The approved accelerated dosing for TWINRIX is series of 4 doses given on days 0, 7, and 21 to 30 followed by a booster dose at month 12. The interval between 2nd and 3rd dose as well as the interval between 3rd and 4th doses were too short. On an unspecified date, the subject also received a dose of unspecified influenza virus vaccine. The 1st, 3rd and 4th injections were fine. The next morning after vaccination with 2nd dose of TWINRIX adult, the subject woke up with no appetite. For the next year he had no appetite when he woke up in the morning and since then, his appetite has gotten worse and worse. He used to weight 180 pounds and he weighed 148 pounds at the time of reporting, He ate only 1/2 a sandwich in a day and typically ate only every 3 days. It has been 3 days since he late ate when this report was made. His thyroid was shot too, and his anger issues and hypertension have gotten worse. In the past month he has also been experiencing nose bleeds. He felt this was slowly killing him and he will not last the year. The only benefit he received was that he did not have Hepatitis C any more. The caller felt that all of this happened because TWINRIX was a type of alpha interferon and these are symptoms of alpha interferon. He said the agency will not release his medical records, and he will be taking this up with a lawyer and will be going to News. He said the agency claimed to have given him only 2 of the TWINRIX injections, but he knew he received all 4, one week apart. The agency tried to claim that one of the injections was a flu vaccine he received, but he said that he received a flu vaccine in addition to 4 TWINRIX injections.
10/30/2005 Reports experiencing nausea/lack of energy/increased phlegm and some soreness at site.  10/31/2005  Soreness at site, red, swollen at site.  No further nausea and reports other than her arm, she feels okay.  Referred to primary doctor.
Patient reports that he developed a rash approximately one week post vaccination that covered his entire stomach up to his chest which wrapped around his sides and covered a portion of his back. Left side of rash was worse than the right. Rash was extremely itchy, raised, and crusty. Patient reported this on 2/24/20 and never saw his physician regarding the issue. Rash has improved. Patient also reports feeling that he still has a sensation that something is "still in his deltoid" wear the vaccine was administered. This sensation he claims is affecting his range of motion. Once again, he did not see his physician regarding this.
pt became coma like (autistic w/in 1month of given 7 vaccines @ one time 10/13/97;
Initial and follow up information has been received from a registered nurse and a consumer concerning his 30 year old wife who works in healthcare, with a history of pneumonia in 1996, 2005 and 2006 who on the morning of 14-MAY-2007 was vaccinated with Pneumovax 23 (lot # 655500/1005F) in the right arm, IM. Concomitantly with tetanus toxoid in the left arm. On 14-MAY-2007 by late afternoon or evening the patient experienced right upper arm soreness, swelling, stiffness and decreased range of motion. A physician saw the patient on 14-MAY-2007 and noted normal strength, shoulder was edematous and tender to palpation at the injection site. There was tenderness in forward flexion. The patient was given Celebrex and told to ice the injection site area. On 15-MAY-2007 the patient continued to complain of right shoulder pain. The patient was reporting swelling of the right hand. The patient reported the pain intensity was an 8 out of 10. The physician noted joint pain and swelling. There was decreased motion in the shoulder, mild erythema, warm to touch of the upper shoulder and deltoid muscle. The right hand noted with mild erythema and edema. Normal range of motion and strength. No joint enlargement or tenderness. The diagnosis was cellulitis. The patient was treated with Cefadin 500 mg 3 times daily and Lortab 5 mg every 4 to 6 hours as needed for pain. The patient was given an injection of Decadron 4 mg and Kenalog 40. The patient reported to the nurse on 17-MAY-2007 the arm is better. On 21-MAY-2007 the consumer reported that his wife did not experience swelling and pain because of the vaccine, but because of the location. Consumer reported that the vaccine was administered in the right shoulder. At the time of the report, the patient was recovering. The reporting registered nurse considered stiffness, decreased range of motion, cellulitis, and joint pain to be disabling since the patient had missed work. Additional information has been requested.
Patient told us that she had gone to urgent care over the weekend to have her injection site looked at. she said it became red and inflamed and hot for about 3 inches all around the site. She was given a steroid shot at urgent care and then told to take Benadryl when she got home.
pt recv vax 29JUL97 @ 845AM;pt woke up from nap around 1030AM-uncontrollable crying, trembling temp 99.6 ax;called MD around 1130AM ordered DPH;crying improved but trembling cont 1-1 1/2hr p/stopped crying;29JUL97 both legs red & swollen;
pt recv vax & exp fever, weakness, nausea & did not feel well; No further details were provided;
I was told by VAERS phone call to report this as an AE:  COVID Positive on November 14, 2022 (one month after vaccine).   Symptoms were fever, chills, muscle and joint aches for first two days; cough, sore throat and post-nasal drip for more than one month; bruised big toenails both feet on day 3 and day 6.  Two months after COVID + suddenly had a torn meniscus in my 'good' knee without having injured or overused it.  It just suddenly happened.
fever, headache, swelling left arm, axillary, cervical, clavicular lymphadenopathy 8 days post receipt primary SPV and FLUMIST. Tmax 104.0 on 9/22/2008; headache severity progressed to 9/10 9/23/2008; 3 satellite lesions around SPV site, date first noted unknown; 2 possible autoinoc lesions: noticed over right thumb pad 9/20/2008; noticed between right 4th/5th toe 9/23/2008; small round macule noted on upper lip 9/24/2008; seen in ER 9/22; followed up at another hospital 9/23. 9/26/2008 bilateral wrist and finger swelling/pain; single erythematous macule over left 1st and right 5th MCP joint. As of 10/1/2008 symptoms resolved. Symptoms: Joint pain, Isolated, swelling, lesions, macule, lesions, macule, lesions, pustule, fever, headache, general, lesions, pustule, lesions, pustule.
noticed very sparse axillary hair growth on the side vaccine was administered.; This is a spontaneous report received from a non-contactable reporter(s) (Physician).  A patient (no qualifiers provided) received bnt162b2 (COMIRNATY), administered in arm, administration date Sep2020 (Batch/Lot number: unknown) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HAIR GROWTH ABNORMAL (non-serious) with onset 2021, outcome "unknown", described as "noticed very sparse axillary hair growth on the side vaccine was administered."  No follow-up attempts are possible. No further information is expected.
Tender Left arm became sore by 9 PM. During the night, developed temp in the 99.1-99.5 range despite extra strength Tylenol every 8 hrs.  with  headache. On awakening, noted nerve pain I had related to Hamstring injury I finally thought I'd gotten rid of, resurfaced over multiple body parts as did eczema I hadn't seen in years on my arms. experienced underarm pain on attempting to raise arm. And although I know they are routine side effects ,I want to include the tiredness, decreased appetite and joint pain so that you know all facets of my experience. When the fever subsided about 1.5 days later, so did the symptoms although the tiredness lasted yet another day. Used ice packs, pushed fluids and rested in bed.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 14-Jan-2021, PAIN IN EXTREMITY (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
When the nurse administered the vaccine to my 5yo niece, she jerked away, the needle bent and scratched my niece's arm and some vaccine did not enter her arm. The nurse was new to giving vaccines in the first place; Some vaccine did not enter her arm/ Told my sister in law that my niece prob got 90% of the vaccine if she had to guess; When the nurse administered the vaccine to my 5yo niece, she jerked away, the needle bent and scratched my niece's arm; This is a spontaneous report from a contactable reporter (Consumer or other non HCP).   A 5-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in right arm, administration date 11Feb2022 at 16:00 (Lot number: unknown) at the age of 5 years as dose 1, single for COVID-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: PRODUCT ADMINISTRATION ERROR (non-serious) with onset 11Feb2022 at 16:00, outcome "unknown", described as "When the nurse administered the vaccine to my 5yo niece, she jerked away, the needle bent and scratched my niece's arm and some vaccine did not enter her arm. The nurse was new to giving vaccines in the first place"; INCORRECT DOSE ADMINISTERED (non-serious) with onset 11Feb2022 at 16:00, outcome "unknown", described as "Some vaccine did not enter her arm/ Told my sister in law that my niece prob got 90% of the vaccine if she had to guess"; SCRATCH (non-serious) with onset 11Feb2022 at 16:00, outcome "recovered" (an unknown date in Feb2022), described as "When the nurse administered the vaccine to my 5yo niece, she jerked away, the needle bent and scratched my niece's arm". The event "When the nurse administered the vaccine to my 5yo niece, she jerked away, the needle bent and scratched my niece's arm" was evaluated at the emergency room visit. Therapeutic measures were not taken as a result of scratch.  Additional Information: The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. It was reported that when the reporters sister in law asked if the patient needed to get another dose, the nurse did not know the answer and did not administer another one or refer her to anyone for the answer. Since the vaccination, it was unknown whether the patient had been tested for COVID-19.   The lot number for BNT162b2 was not provided and will be requested during follow up.
After receiving vaccines, patient was hospitalized for pneumonia and cellulitis. Patient was then discharged a few days later per nurse at care facility.
This spontaneous report was received from a male medical professional (credentials not specified) (age not reported) reporting on himself via a company representative. There was no information about the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions/allergies. On an unknown date, the patient was vaccinated with the second dose of GARDASIL 9 as prophylaxis (dose, route of administration, lot number and expiration date were not reported). On an unknown date, after the administration of the second dose of the vaccine, the patient experienced redness in and around his eyes and hot flushed feeling around his eyes. The patient was treated with BENADRYL and it relieved the symptoms. On an unknown date, the patient recovered from the events. No further information was provided. The causal relationship between the events and GARDASIL 9 were not reported. Additional information is not expected since the healthcare professional's contact details was not provided.
Area became hot within first 1/2 hour.  Upon visual inspection on 11/4/13 area was red, hot, itchy and swollen and painful.
Lung infection/ pneumonia/lower left lungs affected; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PNEUMONIA (Lung infection/ pneumonia/lower left lungs affected) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037421B) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced PNEUMONIA (Lung infection/ pneumonia/lower left lungs affected) (seriousness criterion medically significant). At the time of the report, PNEUMONIA (Lung infection/ pneumonia/lower left lungs affected) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, X-ray: lower left lungs effected due to pneumonia (abnormal) Lower left lungs effected due to Pneumonia.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The Patient was tested negative for COVID .He has not provided any concomitant medication information.The Patient has his 2 dose scheduled for 23 Apr 2021 and wants to know if he can extend the time frame to get his second dose. Treatment information was not provided.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
my neck swelled up; lumps and bumps became very hard and painful; lumps and bumps became very hard and painful; lumps and bumps became very hard and painful; This is a spontaneous report from a contactable consumer (Patient) or other non-health care professional. A 73-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9265), via an unspecified route of administration, administered in Arm Left on 27Jan2021 (Age at vaccination: 73 years) as single dose for COVID-19 immunisation.  Medical history included chronic lymphocytic leukaemia from an unknown date and unknown if ongoing. The patient previously took benadryl and experienced drug hypersensitivity. The patient previously received first dose of bnt162b2(lot number: EL9261), administered in left arm on 27Jan2021 09:00 AM for COVID-19 immunisation. Patient received 1st dose on 27Jan2021 at 9:00 in left arm with lot number EL9261. Patient did not receive any other vaccine in four weeks. Patient received 7 prescrip-tions and 4 OTC in two weeks. Patient did not have COVID prior vaccination. Patient tested COVID post vaccination. The patient experienced my neck swelled up, lumps and bumps became very hard and painful on 18Feb2021 at 08:00. The patient underwent lab tests and procedures which included sars-cov-2 test which was negative on 08Feb2021. Primary care doctor and oncologist waited for a while, we then tried round of Rituxan. We were trying the chemotherapy, Treanda. Lump were quite painful, and she have not felt well since 17Feb. The outcome of the event was not recovered.   Follow-up attempts are completed. No further information is expected.
Reports staff member hours after receiving the vaccine developing rash and  shortness of breath.  Directed the staff member  (who had received the vaccine ) to ER by supervising program nurse manager.
PT came in the following day at about 10:30 am with itchy hives and tingling lips. OT went to the drug store for BENADRYL. PT came back in and stated the BENADRYL was not working. PT was sent to the ER. PT returned and stated they felt better.
pt recv vax 14APR97 & began to have high pitched prolonged crying @ approx 130PM fever 100.6 R to 101R;given APAP;pt vomited 3X since shots given;muscle tone;